Article
Diagnostic and Prognostic Values of KRAS Mutations on EUS-FNA Specimens and Circulating Tumor DNA in Patients With Pancreatic Cancer.
Clinical and translational gastroenterology - 1 May 2022
Wang Ronghua, Zhao Yuchong, Wang Yun, Zhao Zhenxiong, Chen Qian, Duan Yaqi, Xiong Si, Luan Zhou, Wang Jinlin, Cheng Bin
Abstract excerpt
INTRODUCTION: The ability of carbohydrate antigen 19-9 (CA19-9) to differentiate pancreatic cancer from other benign pancreatic lesions is unsatisfactory. This study explored the diagnostic value of KRAS gene mutations and plasma circulating tumor DNA (ctDNA) in patients with pancreatic cancer. METHODS: The prospective cohort study comprised 149 consecutive patients with solid pancreatic lesions who underwent...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
